Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation

Clinical trial NCT00471133 · COMPLETED

Trial details

NCT number: NCT00471133
Sponsor: Ichor Medical Systems Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)Intraocular Melanoma

Start date: 2007-04-01
Primary completion: 2010-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.